Exactmer manufactures exact polymeric pharmaceuticals, enabling advanced therapies to be provided to all patients in need
Chief Executive Officer & Co-Founder
Andrew is an accomplished entrepreneur and chemical engineering expert. He founded MET Ltd, acquired by Evonik in 2010. With notable roles at Imperial College London and the Rosalind Franklin Institute, he now serves as Vice-Principal at Queen Mary University of London. Leading the Livingston Research Group, his focus lies in membrane technology for organic chemical processes, boasting 340+ papers and 30+ patents.
Chief Scientific Officer & VP of Research & Co-Founder
Piers, a PhD holder from Kings College London, specializes in oligonucleotide and phospholipid synthesis, with a PostDoc from UCL. With expertise in phosphorylated metabolites, he led chemistry in the Livingston Group from 2012 to 2019, focusing on innovative research. Named on 6 patents in Nanostar Sieving, he currently heads the Chemistry team at Exactmer, spearheading groundbreaking research and development efforts.
VP of Manufacturing and Quality
Jerry, a PhD graduate from Imperial College London, brings expertise in Chemical Engineering. With a rich background as a Senior Engineer at Evonik MET, Akzo Nobel, and Reckitt Benckiser Healthcare, he led projects in membrane filter modules and pilot plant scale processes. Joining Exacter in 2021, he now directs the Manufacturing and Quality team, driving operational excellence.
VP of Business Development and Operations
Cristina, a 2016 Physics PhD graduate from the University of Cambridge, boasts experience managing multimillion-pound projects at Imperial College London. Excelling in roles at Symphony Ventures and Panacea Innovation, she’s adept at process optimization and leadership. Since December 2019, she’s played a pivotal role at Exactmer, leading Business and Operations, fostering innovation and success.
VP of Membranes
Scientific Advisor
Read More +John, with 30+ years of expertise in pharmaceutical product development, held VP roles at Novartis and The Medicines Company. His profound knowledge in scaling up peptides and oligonucleotides drives Exactmer's market entry strategy, accelerating growth.
Scientific Advisor
Read More +Brian, a research chemist from Oxford University, brings 40+ years of expertise in bioorganic chemistry, specializing in oligonucleotides and their applications. With leadership roles at EMBL, Heidelberg, and C-level positions in biotech, he excels in CMC activities and process optimization. Currently serving as Managing Director at Chemconsilium CV, he boasts 95 peer-reviewed publications and numerous patents.
Scientific Consultant
Read More +Andras, with an MS in Pharmaceutical Chemistry and a PhD in organic chemistry, boasts extensive experience in API development. His leadership at Janssen Pharmaceutics/Johnson&Johnson led to commercializing three APIs and involvement in 15+ complex projects. With expertise in introducing new technologies and managing European and outsourcing projects, he now serves as a scientific consultant, holding 16 patents and 19 peer-reviewed publications.
Regulatory Advisor
Read More +Graham, a Chartered Engineer, brings 30+ years of expertise in electrical, instrumentation, and control engineering, with a focus on functional safety and hazardous area process design. His career in the specialty chemicals sector encompasses design, construction, operations, and project management. With experience in PEG and monomer process design, he ensures quality and regulatory compliance in high-hazard chemical manufacturing within GMP facilities.
Business and Strategy Advisor
Read More +Achim, active for over two decades in hard-tech entrepreneurship and venture capital, excels as both a founder and investor. With a background in Strategy Consulting and Chemical Engineering R&D, he drives impactful business strategies. Holding a German Chemical Engineering Dr degree and a US MBA, he brings a unique blend of expertise to the table.
Financial Advisor
Read More +Neela, a seasoned Finance Director with 20+ years in pharmaceuticals, excels in R&D finance. Specializing in business partnering, strategic planning, and investment support, she strengthens financial operations for Exactmer's growth. With a background at GSK, including Senior Director Finance, she enhances financial planning capabilities and operational efficiency.
We are committed to support the delivery of first-class advanced pharmaceuticals. Let’s explore how we can work together.
